chr9-130882398-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005157.6(ABL1):​c.1679-1571G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.119 in 152,096 control chromosomes in the GnomAD database, including 1,236 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.12 ( 1236 hom., cov: 32)

Consequence

ABL1
NM_005157.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.31

Publications

7 publications found
Variant links:
Genes affected
ABL1 (HGNC:76): (ABL proto-oncogene 1, non-receptor tyrosine kinase) This gene is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular processes, including cell division, adhesion, differentiation, and response to stress. The activity of the protein is negatively regulated by its SH3 domain, whereby deletion of the region encoding this domain results in an oncogene. The ubiquitously expressed protein has DNA-binding activity that is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function. This gene has been found fused to a variety of translocation partner genes in various leukemias, most notably the t(9;22) translocation that results in a fusion with the 5' end of the breakpoint cluster region gene (BCR; MIM:151410). Alternative splicing of this gene results in two transcript variants, which contain alternative first exons that are spliced to the remaining common exons. [provided by RefSeq, Aug 2014]
ABL1 Gene-Disease associations (from GenCC):
  • congenital heart defects and skeletal malformations syndrome
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • connective tissue disorder
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • bone development disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.182 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005157.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABL1
NM_005157.6
MANE Select
c.1679-1571G>A
intron
N/ANP_005148.2P00519-1
ABL1
NM_007313.3
c.1736-1571G>A
intron
N/ANP_009297.2P00519-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABL1
ENST00000318560.6
TSL:1 MANE Select
c.1679-1571G>A
intron
N/AENSP00000323315.5P00519-1
ABL1
ENST00000372348.9
TSL:1
c.1736-1571G>A
intron
N/AENSP00000361423.2P00519-2
ABL1
ENST00000929254.1
c.1676-1571G>A
intron
N/AENSP00000599313.1

Frequencies

GnomAD3 genomes
AF:
0.119
AC:
18048
AN:
151978
Hom.:
1232
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.185
Gnomad AMI
AF:
0.0526
Gnomad AMR
AF:
0.123
Gnomad ASJ
AF:
0.0660
Gnomad EAS
AF:
0.0605
Gnomad SAS
AF:
0.110
Gnomad FIN
AF:
0.0919
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.0913
Gnomad OTH
AF:
0.0909
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.119
AC:
18089
AN:
152096
Hom.:
1236
Cov.:
32
AF XY:
0.121
AC XY:
8966
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.186
AC:
7692
AN:
41444
American (AMR)
AF:
0.123
AC:
1884
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0660
AC:
229
AN:
3470
East Asian (EAS)
AF:
0.0602
AC:
312
AN:
5180
South Asian (SAS)
AF:
0.110
AC:
530
AN:
4826
European-Finnish (FIN)
AF:
0.0919
AC:
973
AN:
10590
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0913
AC:
6207
AN:
67986
Other (OTH)
AF:
0.0919
AC:
194
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
791
1581
2372
3162
3953
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
204
408
612
816
1020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0894
Hom.:
1130
Bravo
AF:
0.122
Asia WGS
AF:
0.107
AC:
371
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.066
DANN
Benign
0.59
PhyloP100
-1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3808814; hg19: chr9-133757785; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.